Dr. Omar Amed Tolaymat, MD

Dr. Tolaymat practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Tolaymat's NPI, 1588082192, was assigned on April 1, 2014. Dr. Tolaymat graduated from FIU Herbert Wertheim College of Medicine in 2014. Dr. Tolaymat holds Florida license ME131106.

Dr. Tolaymat's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Tolaymat's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. Dr. Tolaymat is also affiliated with Mayo Clinic Hospital. The medical group on file is Mayo Clinic Jacksonville. Dmand AI also links Dr. Tolaymat to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tolaymat practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Tolaymat's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Tolaymat is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Tolaymat's licenses on file in 3 states: Florida, Georgia and Minnesota.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, gout, joint arthropathy, joint pain, lupus and muscle disease among the conditions Dr. Tolaymat treats.

CMS data shows 656 Medicare services from Dr. Tolaymat across 7 procedure codes in 2024, for 188 Medicare patients. Medicare paid $38,111 for them. Every service was in an office.

CMS counts 188 Medicare patients who saw Dr. Tolaymat in 2024. The largest group is 65 to 74, with 85 patients. 75% of them have arthritis, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tolaymat's median patient age at 66, with 74% women.

In 2024, Dr. Tolaymat wrote 505 Medicare Part D claims for 112 patients. 76% of them were for generic drugs. CMS names the drug for 420 of them, across 10 drugs with 11 or more claims each, at $743,727 in total drug cost. In 2023, CMS named 283 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Tolaymat for performance year 2024, reported through an alternative payment model (APM). Dr. Tolaymat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tolaymat as offering telehealth.

Dmand AI links 6 papers to Dr. Tolaymat, published from 2016 to 2020. 2018 was the busiest year, with 2. Dr. Tolaymat's most frequent co-authors are Florentina Berianu, MD, Andy Abril, MD and Andrew W. Bowman, MD.

CMS Open Payments shows 17 general payments to Dr. Tolaymat from 7 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 95% of the total. Sanofi and Genzyme US Companies paid the most, $435.

Dr. Tolaymat graduated from FIU Herbert Wertheim College of Medicine in 2014.

Dr. Tolaymat is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.